3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma INMD

InMode Ltd.

INMD NASDAQ Biotech & Pharma

Stock factsheet

TickerINMD
ExchangeNASDAQ
ISIN
WKN
SectorBiotech & Pharma
Size class Small Cap
Market capitalisation 959 Mio. USD As of 2026-08-03

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

InMode develops and sells minimally invasive medical devices for aesthetic treatments based on radiofrequency technology. The products are used in areas such as body contouring, skin tightening and gynaecological applications. The company is headquartered in Israel and sells its devices to physicians and clinics worldwide.

Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.

Share price

Price data from TradingView, possibly delayed. Not investment advice.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
InMode Ltd.INMD NASDAQ959 Mio. USD
Avalo Therapeutics, Inc. AVTXNASDAQ 965 Mio. USD
Adlai Nortye Ltd. ANLNASDAQ 947 Mio. USD
Jade Biosciences, Inc. JBIONASDAQ 975 Mio. USD
Replimune Group, Inc. REPLNASDAQ 941 Mio. USD
OPKO Health, Inc. OPKNASDAQ 985 Mio. USD
Janux Therapeutics, Inc. JANXNASDAQ 925 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.